110 Phase II clinical trial of amifostine (WR2721), cisplatin (C), vinblastine (V) (ACV) and thoracic radiation therapy (RT) for unresectable stage III non small cell lung cancer (NSCLC).

cited authors

  • Tannehill, S; Mehta, M; Larson, M; Storer, B; Schiller, J; Kinsella, T

start page

  • 196

volume

  • 32